PharmAla Biotech: Pioneering MDMA Therapy

In this episode of the CanadianSME Small Business Podcast, host Maheen Bari sits down with Nick Kadysh , founder and CEO of PharmAla Biotech, to uncover how this pioneering Toronto-based life sciences company is leading the way in MDMA-assisted therapies for mental health. With a career spanning regulatory leadership roles at JUUL Labs and General Electric Canada, Nick’s journey into biotechnology brings a unique blend of public affairs expertise and innovation to the healthcare space. Through PharmAla’s groundbreaking work, MDMA and MDXX-class molecules are now being manufactured and researched to treat PTSD and support mental health globally. Key Highlights: Regulatory Innovation – Overcoming challenges in MDMA manufacturing and approval. Prescriber’s Portal – A digital solution expanding access to MDMA treatments in Canada. Veteran Mental Health – How MDMA therapy is improving outcomes for PTSD patients. Global Research – PharmAla’s partnerships with leading institutions driving mental health innovation. Special Thanks to Our Partners: RBC: https://www.rbcroyalbank.com/dms/business/accounts/beyond-banking/index.html UPS: https://solutions.ups.com/ca-beunstoppable.html?WT.mc_id=BUSMEWA Constant Contact: https://www.constantcontact.com/landing1/new-marketer?utm_campaign=canadiansme&utm_medium=sponsorlogo&utm_source=brand IHG Hotels and Resorts: https://businessedge.ihg.com/s/registration?language=en_US&CanSME Google: https://www.google.ca/ For more expert insights, visit www.canadiansme.ca and subscribe to the CanadianSME Small Business Magazine. Stay innovative, stay informed, and thrive in the digital age! Disclaimer: The information shared in this podcast is for general informational purposes only and should not be considered as direct financial or business advice. Always consult with a qualified professional for advice specific to your situation.